A randomized trial of 24- vs. 48-week courses of PEG interferon α-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in Taiwan-Reference-Cited by-同舟云学术

A randomized trial of 24- vs. 48-week courses of PEG interferon α-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in Taiwan

Published:2005-11-18 Issue:1 Volume:26 Page:73-81
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:

Author:

Yu Ming-Lung,Dai Chia-Yen,Lin Zu-Yau,Lee Li-Po,Hou Nei-Jen,Hsieh Ming-Yen,Chen Shinn-Cherng,Hsieh Ming-Yuh,Wang Liang-Yen,Chang Wen-Yu,Chuang Wan-Long

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2005.01196.x/fullpdf

Reference29 articles.

1. Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C;Lai;Gastroenterology,1996

2. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group;Mchutchison;N Engl J Med,1998

3. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT);Poynard;Lancet,1998

4. Standardization of hepatitis C virus RNA quantification;Pawlotsky;Hepatology,2000

5. Consensus statement;EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999.;J Hepatol,1999

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Depression-free after Interferon-α exposure indicates less incidence of depressive disorder: A longitudinal study in Taiwan;Brain, Behavior, and Immunity;2020-08

2. Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis;PLOS ONE;2018-02-21

3. Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapy;Oncotarget;2016-08-17

4. A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection;Liver International;2016-03-23

5. Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection;Hepatology International;2015-11-05